Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 728 of 6351
-
Can adding venetoclax let CLL patients pause therapy?
Disease control OngoingThe main purpose of the study is to evaluate if adding venetoclax to participants receiving cBTKi for the 1L CLL can achieve deep durable remissions of undetectable measurable residual disease \[uMRD \< or 10\^-4 in peripheral blood (PB)\] by end of combination treatment (EOCT) t…
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug aims to stop CMV from coming back after transplant
Disease control Recruiting nowThis study is designed to assess how effective letermovir is in preventing recurrence of cytomegalovirus (CMV) infection in adult kidney or kidney/pancreas transplant recipients who are UW Health patients. Participants will be in the study for about 6 months.
Phase 3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New vaccine aims to train immune system against HPV cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety and efficacy of a potential new treatment called Lenti-HPV-07 in patients with a cancer induced by Human Papilloma Virus (HPV). The main questions aim to answer are: * Is Lenti-HPV-07 safe? * Does Lenti-HPV-07 induce …
Phase 1/2 • Sponsor: Theravectys S.A. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Promising cocktail aims to shrink esophageal tumors before surgery
Disease control Recruiting nowEsophageal cancer is a prevalent digestive tract tumor, with around 400,000 new cases and 300,000 deaths globally each year. In the past few decades, surgery, radiotherapy, chemotherapy and other treatments were continuously improved, however, the mortality of esophageal squamous…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for kids with Crohn's: oral drug trial launches
Disease control Recruiting nowCrohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This study will assess…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for tough-to-treat pancreatic cancer? drug combo enters phase 2 trial
Disease control OngoingThe goal of this research study is to asses the safety and efficacy of the combination of AGEN1423 and Botensilimab with or without chemotherapies, gemcitabine and nab-paclitaxel, for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC) which has progressed after at …
Phase 2 • Sponsor: Bruno Bockorny • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a simple test spot sudden-onset neuropsychiatric syndrome in kids?
Knowledge-focused Recruiting nowPediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a complex neuropsychiatric disorder characterized by the abrupt onset of symptoms and currently diagnosed mainly on clinical criteria, as reliable diagnostic biomarkers are still lacking. The primary objective of this proj…
Sponsor: University of Cagliari • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
A surgical showdown: can a newer bariatric procedure outsmart blood sugar drops?
Disease control Recruiting nowObesity is a major global health problem. Bariatric surgery is the most effective treatment, leading to substantial weight loss and improvement in obesity-related comorbidities. The most commonly performed procedures are Laparoscopic Roux-en-Y gastric bypass (LRYGB) and Laparosco…
Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a 48-Hour fast tame Chemotherapy's worst side effects?
Symptom relief Recruiting nowThis research is being done to test the feasibility of 24-48 hours of water-only fasting to improve delivery of 4 cycles of chemotherapy in those receiving breast cancer treatment either before or after surgery.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
A new care model aims to heal the hidden wounds of violence
Knowledge-focused Recruiting nowGender-based or sexual violence, or violence against women (VAW), is a global public health problem affecting around 30% of women over the age of 15, with significant consequences for physical and mental health, including depression and post-traumatic stress disorder (PTSD). In …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Grape seed extract put to the test for blood pressure and heart health
Disease control Recruiting nowInflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research wil…
Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo targets Hard-to-Treat lung cancer mutation
Disease control Recruiting nowThis phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first started (primary site) to other places in the body (stage IV) or that has come ba…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New biosimilar RPH-002 takes on erbitux in head and neck cancer showdown
Disease control CompletedThe primary objective of the study is to evaluate the comparability of efficacy, safety, and immunogenicity of RPH-002 and Erbitux® when administered in combination with docetaxel and cisplatin as first-line therapy in patients with advanced head and neck squamous cell carcinoma
Phase 3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New biologic drug netakimab tested in kids with psoriasis
Disease control OngoingThe aim of the study is to evaluate the efficacy and safety of netakimab compared with placebo in a pediatric population of subjects over 6 years of age with moderate to severe plaque psoriasis. The study will have randomized, double-blind, placebo-controlled study with open-arm …
Phase 3 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain-Spray chemo cocktail targets breast Cancer's deadliest spread
Disease control Recruiting nowEvaluate the efficacy and safety of Intrathecal Administration of Thiotepa in Combination with Methotrexate via the Ommaya Reservoir in Breast Cancer with Leptomeningeal Metastasis
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Blood test could spot rare nerve tumors years earlier in NF1 patients
Knowledge-focused By invitation onlyThe goal of this observational study is to determine if a liquid biopsy (i.e. blood test) is an effective clinical tool for monitoring the development of malignant peripheral nerve sheath tumor (MPNST) among adults (18 years and older) with Neurofibromatosis Type 1 (NF1), compare…
Sponsor: David Miller • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
A phone app takes on the opioid crisis in high-risk workplaces
Prevention CompletedWorkWell is a mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and healthcare workers. Two sequential randomized factorial optimization trials evaluated intervention lessons targeting opioid-related bel…
Sponsor: Prevention Strategies, LLC • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
One-Shot gene therapy could replace monthly eye injections for wet AMD
Disease control OngoingThis will be a clinical study to assess initial safety and tolerability of IVT ABI-110 in patients diagnosed with wet macular degeneration (wAMD), including symptomatic macular PCV.
Phase 1/2 • Sponsor: Avirmax Biopharma Inc • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a diabetes drug tame PCOS symptoms?
Disease control CompletedThe Study aims to determine the proposed positive influence of Sitagliptin in manipulating hormonal , metabolic and inflammatory parameters in the treatment of Polycystic ovary syndrome and subsequent infertility
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental cocktail aims to tackle returning brain tumors
Disease control OngoingThis study consists of 2 portions. The phase 2 portion is an open-label, single-arm study to evaluate the safety and efficacy of NAI, PD-L1 t-haNK, and bevacizumab combination therapy in participants with recurrent or progressive GBM. The phase 2B portion is an open-label, random…
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC